Mastacchi R et al. |
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. |
1986 |
Agents Actions |
pmid:3518359
|
Northover AM |
Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro. |
1990 |
Agents Actions |
pmid:2111079
|
Mencia-Huerta JM et al. |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process? |
1981 |
Agents Actions |
pmid:7053072
|
Lewis AJ et al. |
The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation. |
1984 |
Agents Actions |
pmid:6152379
|
Boonen GJ et al. |
Activation of neutrophil migration by dioctanoyl-sn-glycerol and fMet-Leu-Phe is controlled by different pathways. |
1993 |
Agents Actions |
pmid:8317308
|
Okamoto H et al. |
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor. |
1992 |
Agents Actions |
pmid:1388318
|
Bette P and Bienvenue A |
Exchange of a spin-labeled analog of PAF-acether between micelles, serum albumin and model membranes. |
1982 |
Agents Actions |
pmid:7164940
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of PAF-acether. Preliminary results after the intravenous administration of a 3H-labelled product to the rabbit. |
1982 |
Agents Actions |
pmid:7164941
|
Morgat JL et al. |
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. |
1982 |
Agents Actions |
pmid:7164942
|
Convert O et al. |
1H NMR of PAF-acether: influence of solvent on its structure. |
1982 |
Agents Actions |
pmid:7164943
|
Borrel MC et al. |
Additional techniques for the total synthesis of PAF-acether. |
1982 |
Agents Actions |
pmid:7164944
|
Benveniste J et al. |
Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. |
1982 |
Agents Actions |
pmid:7164945
|
Miyagawa H et al. |
The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils. |
1992 |
Agents Actions |
pmid:1456179
|
Perales J et al. |
Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. |
1992 |
Agents Actions |
pmid:1295374
|
Trebien HA and Calixto JB |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. |
1989 |
Agents Actions |
pmid:2660497
|
Jouvin-Marche E et al. |
Platelet-activating factor (PAF-acether), an activator of neutrophil functions. |
1982 |
Agents Actions |
pmid:6299078
|
Caillard CG et al. |
Hypotensive activity of PAF-acether in rats. |
1982 |
Agents Actions |
pmid:6299079
|
Raff GW et al. |
Procoagulant property of platelet activating factor (PAF). |
1993 |
Agents Actions |
pmid:8273543
|
Wong CW et al. |
Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor. |
1992 |
Agents Actions |
pmid:1414679
|
Tran A et al. |
Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin. |
1992 |
Agents Actions |
pmid:1414687
|